Scientific Publications

Publication Highlights

Newly Diagnosed Anaplastic Astrocytoma: > 23 Year Survival in a 31-Year and 11-Month-Old Female Treated with Antineoplastons

Recurrent/Persistent Glioblastoma: Complete Response and 24 Years Disease-free Survival in a 45-Year-Old Female Treated with Antineoplastons (Successful Treatment of Glioblastoma with Antineoplastons).

Newly Diagnosed Glioblastoma: Partial Response and > 27 Years Overall Survival in 37-Year-Old Male Treated with Antineoplastons (Treatment of Glioblastoma with Antineoplastons).

Resolution of clinical signs, a complete response, and long-term survival (> 23 Years) in a 3 and ½ month female with a newly diagnosed diffuse intrinsic pontine glioma treated with antineoplastons.

Long-term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG)

Progressive, Multicentric, Midline, Low-grade Glioma: Survival Greater Than 24.8 Years in Three Patients Treated with Antineoplastons A10 and AS2-1 in Phase II Studies

Recurrent/Disseminated Choroid Plexus Carcinoma: Overall Survival of > 23.6 Years in a One-Year and Nine-Month-Old Female Treated with Antineoplastons.

Recurrent Desmoplastic Infantile Ganglioglioma Treated with Antineoplastons: Partial Response and Overall Survival of > 11.8 Years in a Ten-Month-Old Female

Recurrent Pilocytic Astrocytoma: Treatment with Antineoplastons, Complete Response, and > 27 Years Overall Survival

Recurrent Medulloblastoma: Complete Response and > than 21 Years and Five Months Overall Survival in a One-Year and Seven Month-Old Male Treated with Antineoplastons

Inoperable Optic Pathway Glioma: A Seven-Year-Old Male with >35 Years Overall Survival Following Treatment with Antineoplastons

Persistent pineoblastoma: Complete response and >26 years overall survival in a ten-month-old female treated with antineoplastons

December 16th, 2022

Dr. S.R. Burzynski and his associates continuously report new scientific information, advancing the frontiers of cancer treatment. Their pioneering research opens doors to innovative therapies, offering hope to patients and valuable insights for medical professionals worldwide. By staying at the forefront of scientific discovery, they strive to transform cancer care and empower both patients and doctors in their pursuit of a cure. The following is a list of science publications by date, showcasing their ongoing contributions to the fight against cancer.

Date: 2024

Title: Recurrent Desmoplastic Infantile Ganglioglioma Treated with Antineoplastons: Partial Response and Overall Survival of > 11.8 Years in a Ten-Month-Old Female.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Int J Brain Disord Treat 10:050.doi.org/10.23937/2469-

5866/1410050

Date: 2024

Title: Recurrent/Disseminated Choroid Plexus Carcinoma: Overall Survival of > 23.6 Years in a One-Year and Nine-Month-Old Female Treated with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Journal of Medical Research and Case Reports 6(1). DOI:

10.5281/zenodo.11387006

Date: 2024

Title: Recurrent Pilocytic Astrocytoma: Treatment with Antineoplastons, Complete Response, and > 27 Years Overall Survival

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Recent Adv Clin Trials. 2024; 4(1); 1-7.

Date: 2023

Title: Recurrent Medulloblastoma: Complete Response and > than 21 Years and Five Months Overall Survival in a One-Year and Seven-Month-Old Male Treated with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Journal of Oncology Research Review & Reports. 2023 Vol 4(4): 1-6;

SRC/JONRR-186

Date: 2023

Title: Inoperable Optic Pathway Glioma: A Seven-Year-Old Male with >35 Years Overall Survival Following Treatment with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: European Journal of Clinical Medicine, 4(5), 9–14.https://doi.org/10.24018/clinicmed.2023.4.5.312

Date: 2023

Title: Persistent pineoblastoma: complete response and > 26 years overall survival in a ten-month-old female treated with antineoplastons.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Biomed Res Clin Prac, 2023.

DOI: 10.15761/BRCP.1000227

Date: 2023

Title: Newly diagnosed Anaplastic Astrocytoma: > 23 Year Survival in a 31-Year and 11-Month-Old Female Treated with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Neurol Neurosci. 2023;4(2):1-6.

DOI: 10.33425/2692-7918.1051

Date: 2022

Title: Newly Diagnosed Glioblastoma: Partial Response and > 27 Years Overall Survival in 37-Year-Old Male Treated with Antineoplastons (Treatment of Glioblastoma with Antineoplastons).

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Recent Adv Clin Trials. 2022; 2(2): 1-7.

DOI: 10.33425/2771-9057.1018

Date: 2022

Title: Recurrent/Persistent Glioblastoma: Complete Response and 24 Years Disease-free Survival in a 45-Year-Old Female Treated with Antineoplastons (Successful Treatment of Glioblastoma with Antineoplastons).

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Cancer Stud Ther J Volume 7(3): 1–6.

DOI: 10.31038/CST.2022733

Date: 2022

Title: Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1.

Authors: Burzynski, S., Burzynski, G., Janicki, T., Beenken, S.

Published By: Neurology and Neuroscience Volume 3(3): 1–9.

DOI: 10.33425/2692-7918.1036

Date: 2022

Title: Newly-Diagnosed Multicentric Pilocytic Astrocytoma: Complete Response and > 22 Years Survival in a Six Year and Nine-Month-Old Female Treated with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G., Janicki, T., Beenken, S.

Published By: International Journal of Clinical Oncology and Cancer Research Volume 7(3): 76–82.

DOI: 10.11648/j.ijcocr.20220703.15

Date: 2022

Title: Recurrent and Progressive Ganglioglioma in an 11-Year-Old Male Treated with Antineoplastons A10 and AS2-1: A Case Report.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T.J., Weaver, R.A.

Published By: Biomedical Journal of Scientific & Technical Research Volume 37(1): 1–6.

DOI: 10.26717/BJSTR.2022.37.005999

Date: 2022

Title: Twenty-Two Year Survival in 15-Year-Old Female with a Recurrent Posterior Fossa Ependymoma Treated with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Oncology Clinics and Research Volume 5(1): 99–105.

Date: 2022

Title: A 25-Year-Old Female with Diffuse Intrinsic Pontine Glioma Surviving for More than Nine Years Following Treatment with Antineoplastons.

Authors: Burzynski, S.R., Burzynski, G., Janicki, T., Beenken, S.

Published By: International Journal of Clinical Oncology and Cancer Research Volume 7(1): 1–7.

DOI: 10.11648/j.ijcocr.20220701.11

Date: 2021

Title: Diffuse Intrinsic Pontine Glioma in an 11-Year-Old Female Treated with Antineoplastons: Complete Response and >25 Years Survival.

Authors: Burzynski, S., Burzynski, G., Janicki, T., Beenken, S.

Published By: Pediatrics and Neonatal Medicine Volume 1(2): 1–5.

DOI: 10.33425/2768-0363.1010

Date: 2021

Title: Long-Term Survival (23 Years) in a 26-Year-Old Male after Antineoplaston Therapy for a Progressive, Diffuse Intrinsic Pontine Glioma: A Case Report.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: International Journal of Brain Disorders and Treatment Volume 6: 038.

DOI: 10.23937/2469-5866/1410038

Date: 2021

Title: Resolution of Clinical Signs, a Complete Response, and Long-Term Survival (>23 Years) in a 3 and ½ Month Female with a Newly Diagnosed Diffuse Intrinsic Pontine Glioma Treated with Antineoplastons.

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S., Beenken, S.

Published By: Biomedical Research and Clinical Practice Volume 6: 1–6.

DOI: 10.15761/BRCP.1000220

Date: 2021

Title: Long-Term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG).

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S., Beenken, S.

Published By: International Journal of Radiology and Imaging Technology Volume 7(1): 1–6.

DOI: 10.23937/2572-3235.1510073

Date: 2019

Title: Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T., Beenken, S.

Published By: Cancer and Clinical Oncology; Vol.8, No. 1; 2019.

DOI: 10.5539/cco.v8n1p1

2018-2008 Science Publications: Date: 2017

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Marszalek, A.

Published By: Journal of Cancer Therapy Volume 8(2): 15–26.

DOI: 10.4236/jct.2017.82015

Date: 2017

Title: Antineoplastons A10 and AS2-1 in the Treatment of Children with Optic Pathway Glioma: Final Report for Protocol BT-23

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S.

Published By: Cancer and Clinical Oncology Volume 6(1): 25–31.

DOI: 10.5539/cco.v6n1p25

Date: 2016

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S.

Published By: Journal of Cancer Therapy Volume 7(12): 837–850.

DOI: 10.4236/jct.2016.712083

Date: 2016

Title: Primary CNS Tumors and Leptomeningeal, Disseminated and/or Multicentric Disease in Children Treated in Phase II Studies with Antineoplastons A10 and AS2-1

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S.

Published By: Cancer and Clinical Oncology Volume 5(2): 38–45.

DOI: 10.5539/cco.v5n2p38

Date: 2015

Title: A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents.

Authors: Burzynski, S.R., Burzynski, G.S., Brookman, S.

Published By: Journal of Cancer Therapy Volume 6(1): 1–4.

DOI: 10.4236/jct.2015.61006

Date: 2015

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S.

Published By: Journal of Cancer Therapy Volume 6(12): 1161–1172.

DOI: 10.4236/jct.2015.612116

Date: 2015

Title: Comprehensive Genomic Profiling of Recurrent Classic Glioblastoma in a Patient Surviving Eleven Years Following Antineoplaston Therapy

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S.

Published By: Cancer and Clinical Oncology Volume 4(2): 41–46.

DOI: 10.5539/cco.v4n2p41

Date: 2015

Title: Long-Term Survival (Over 20 Years), Complete Response, and Normal Childhood Development in Medulloblastoma Treated with Antineoplastons A10 and AS2-1

Authors: Burzynski, S.R., Burzynski, G.S., Marszalek, A., Janicki, T.J., Martinez-Canca, J.F.

Published By: Journal of Neurology & Stroke Volume 2(3): 1–6.

DOI: 10.15406/jnsk.2015.02.00054

Date: 2015

Title: Complete response and Long-term survival (>20 years) of a child with tectal glioma: A case report.

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T.J., Marszalek, A.

Published By: Pediatr Neurosurg

DOI: 10.1016/j.pediatrneurol.2012.07.004

Date: 2015

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S., Marszalek, A.

Published By: Journal of Cancer Therapy Volume 6(4): 334–344.

DOI: 10.4236/jct.2015.64036

Date: 2015

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Newly-Diagnosed Anaplastic Astrocytoma—Final Report (Protocol BT-08)

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S., Marszalek, A.

Published By: Cancer and Clinical Oncology Volume 4(1): 28–35.

DOI: 10.5539/cco.v4n1p28

Date: 2015

Title: Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case Report

Authors: Burzynski, S.R., Burzynski, G.S., Marszalek, A., Janicki, T.J., Martinez-Canca, J.F.

Published By: Journal of Neurology & Stroke Volume 2(6): 1–6.

DOI: 10.15406/jnsk.2015.02.00072

Date: 2015

Title: A Phase II Study of Antineoplastons A10 and AS2-1 Injections in Adult Patients with Recurrent Anaplastic Astrocytoma—Final Report (Protocol BT-15)

Authors: Burzynski, S.R., Janicki, T., Burzynski, G.S.

Published By: Cancer and Clinical Oncology Volume 4(2): 13–19.

DOI: 10.5539/cco.v4n2p13

Date: 2014

Title: Long-term survival (>20 years) of a child with brainstem glioma treated with antineoplastons A10 and AS2-1: a case report.

Authors: Burzynski, G.S., Janicki, T.J., Marszalek, A.

Published By: Neuro-Oncology 2014; vol.16 (Suplement 5) v175-v177,

DOI:10.1093

Date: 2014

Title: Long-term progression-free survival of recurrent glioblastoma multiforme treated with a combination of targeted agents: a case report.

Authors: Burzynski, S.R., Burzynski, G.S.

Published By: Neuro-Oncology 2014; vol.16 (Suplement 5); v11

Date: 2014

Title: Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Brookman, S.

Published By: Journal of Cancer Therapy Volume 5(13): 1288–1305.

DOI: 10.4236/jct.2014.513128

Date: 2014

Title: Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Recurrent Advanced Pancreatic Cancer—A Potential Strategy for Improved Survival

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Brookman, S.

Published By: Journal of Cancer Therapy Volume 5(12): 1145–1163.

DOI: 10.4236/jct.2014.512113

Date: 2014

Title: Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Brookman, S.

Published By: Journal of Cancer Therapy Volume 5(12): 1127–1144.

DOI: 10.4236/jct.2014.512116

Date: 2014

Title: Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Brookman, S.

Published By: Journal of Cancer Therapy Volume 5(14): 1311–1324.

DOI: 10.4236/jct.2014.514144

Date: 2014

Title: A Phase II study of Antineoplaston A10 and AS2-1 in patients with brainstem gliomas Final report (Protocol BT-11).

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Marszalek, A.

Published By: Neuro-Oncology 2014; vol.16 (Suplement 5); v16

Date: 2014

Title: Long-term survival (over 15 years) of pathologically confirmed recurrent glioblastoma multiforme: A case report.

Authors: Janicki T.J., Burzynski G.S., Burzynski S.R.

Published By: Neuro-Oncology 2014; 16 (suppl. 5): v14-15.

Date: 2014

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21)

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S.

Published By: Journal of Cancer Therapy Volume 5(10): 946–956.

DOI: 10.4236/jct.2014.510100

Date: 2014

Title: Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival

Authors: Burzynski, S.R., Burzynski, G.S., Janicki, T.J.

Published By: Journal of Cancer Therapy Volume 5(10): 957–976.

DOI: 10.4236/jct.2014.510101

Date: 2014

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22)

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Marszalek, A., Brookman, S.

Published By: Journal of Cancer Therapy Volume 5(10): 977–988.

DOI: 10.4236/jct.2014.510102

Date: 2014

Title: The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme

Authors: Burzynski, S.R., Patil, S.S.

Published By: Journal of Cancer Therapy Volume 5(10): 930–946.

DOI: 10.4236/jct.2014.510099

Date: October 2014

Title: Long-term Survival (>13 Years) in a Child With Recurrent Diffuse Pontine Glioma

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Marszalek, A.

Published By: Journal of Pediatric Hematology/Oncology Volume 36(7): e433–e439.

DOI: 10.1097/MPH.0000000000000218

Date: 2014

Title: Long-term survival (over 20 years), complete response and normal childhood development in medulloblastoma (PNET) without recurrence: a case report. MB-039-020.

Authors: Janicki, T.J., Burzynski, S.R., Burzynski, G., Marszalek, A.

Published By: Neuro-Oncology 2014;16(Suppl. 1):i80.

Date: 2014

Title: A Phase II Study of Antineoplastons A10 and AS2-1 in Children with High-Grade Glioma. Final Report (Protocol BT-06), and Review of Recent Trials

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Marszalek, A.

Published By: Journal of Cancer Therapy Volume 5(6): 560–572.

DOI: 10.4236/jct.2014.56065

Date: 2014

Title: The Response and Survival of Children with Recurrent Diffuse Intrinsic Pontine Glioma Based on Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Glioma

Authors: Burzynski, S.R., Janicki, T.J., Burzynski, G.S., Marszalek, A.

Published By: Child's Nervous System Volume 30(12): 2063–2072.

DOI: 10.1007/s00381-014-2401-z

Date: 2014

Title: Tratamentul multitintit cu antineoplastoni in glioamele cerebrale.

Authors: Burzynski, S.R.

Published By: Revista Buletinul Medicina Familiei (RBMF), Volume 1, Issue 27, January 2014.

Date: 2014

Title: Implication of oxidative stress-induced oncogenic signaling pathways as a treatment strategy for neurodegeneration and cancer.

Authors: Aliev, G., Burzynski, G., Ashraf, G.M., Jabir, N.R., Cacabelos, R., Benberin, V.V., Burzynski, S.R.

Published By: Syst Biol Free Rad Antioxid 2014; 2325-2347;

DOI: 10.1007/978-3-642-30018-9.

Date: 2014

Title: Long-term survival (over 20 years) and pathologically confirmed complete response in pediatric anaplastic astrocytoma: a case report. HG-017.

Authors: Burzynski, G., Janicki, T., Burzynski, S.R., Marszalek, A.

Published By: Neuro-Oncology 2014;16(Suppl. 1):i44.

Date: 2014

Title: A phase II study of antineoplastons A10 and AS2-1 in children with recurrent, refractory or progressive primary brain tumors based on protocol BT-22. CT-004.

Authors: Burzynski, S.R., Janicki, T., Burzynski, G., Marszalek, A.

Published By: Neuro-Oncology 2014;16(Suppl. 1):i10.

Date: 2014

Title: Changed gene expression and longevity in honeybees (Apis mellifera) fed with phenylbultyrate- and phenylacetylglutaminate- supplamented diet.

Authors: Burzynski, S., Paleolog, J., Patil, S.

Published By: Medycyna Weterynaryjna 69 (12), 753-759, 2013.

Date: 2014

Title: Long-term survival (over 13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report. N-089

Authors: Burzynski, S., Janicki, T., Burzynski, G., Marszalek, A.

Published By: Neuro-Oncology 2013;15(Suppl. 3):iii120.

Date: 2013

Title: Mitochondria specific antioxidants and their derivatives in the context of the drug development for neurodegeneration and cancer.

Authors: Aliev, G., Palacios, H.H., Cacabelos, P., Cacabelos, R., Burzynski, G., Burzynski, S.R.

Published By: Drug Designing 2013;2(1):103.

DOI:10.4172/2169-0138.1000103

Date: 2013

Title: A phase II study of antineoplastons A10 and AS2-1 in adult patients with recurrent glioblastoma multiforme based on protocol BT-21. NO-020.

Authors: Burzynski, G., Burzynski, S.R., Janicki, T., Marszalek, A.

Published By: Neuro-Oncology 2013;15(Suppl. 3):iii103.

Date: 2013

Title: A phase II study of antineoplastons A10 and AS2-1 in pediatric recurrent diffuse intrinsic pontine glioma. NO-021.

Authors: Burzynski, S., Janicki, T., Burzynski, G., Marszalek, A.

Published By: Neuro-Oncology 2013;15(Suppl. 3):iii103.

Date: 2013

Title: A phase II study of antineoplastons A10 and AS2-1 (ANP) in children with high-grade glioma (Protocol BT-06). NO-058.

Authors: Janicki, T.J., Burzynski, S.R, Burzynski, G.S., Marszalek, A.

Published By: Neuro-Oncology 2013;15(Suppl. 3):iii112.

Date: 2012

Title: Phenylacetylglutaminate in combination with Phenylbutyrate effectively inhibits growth of brain tumor cell In Vitro. P.003.

Authors: Patil, S., Burzynski, S.R., Mrowczynski, E., Grela, K.

Published By: Neuro-Oncology 2012 Vol. 14 Supplement 3, iii16.

Date: 2012

Title: Phenylacetylglutaminate and Phenylacetate in combination Upregulate VDUP1, cause cell cycle blockade and Apoptosis in U87 Glioblastome cells.

Authors: Patil, S., Burzynski, S.R, Mrowczynski, E., Grela, K., Chittur, S.

Published By: Journal of Cancer Therapy, 2012, 3, 192-200.

DOI:10.4236/jct.2012.33028

Date: 2011

Title: The larval diet supplemented with sodium phenylacetylglutaminate influences the worker cuticle proteolytic system in honeybees (Apis mellifera).

Authors: Pateolog, J., Strachecka, A., Burzynski, S.R., Olszewski, K., Borsuk, G.

Published By: Journal of Apicultural Science Vol.55 No. 2, 2011.

Date: 2011

Title: Treatment of esthesioneuroblastoma and nonsmall cell lung cancer with phenylbutyrate.

Authors: Burzynski, S.R., Nagy-Kubove, E.

Published By: Journal of Cancer Therapy 2011,2,518-522.

doi:10.4236/jct.2011.24071

Date: 2011

Title: Successful Treatment of Recurrent Triple-Negative Breast Cancer with Combination of Targeted Therapies.

Authors: Burzynski, S.R., Marquis, A., Nagy-Kubove, E., Janicki, T.

Published By: Journal of Cancer Therapy 2011, 2, 372-376.

DOI:10.4236/jct.2011.23050

Date: 2010

Title: A Phase II Study of Antineoplaston A-10 and AS-1 Injections in Children with Low-Grade Astrocytomas.

Authors: Burzynski, S.R., Weaver, R., Janicki, T.J., Szymkowski, B., Acelar, S., Burzynski, G.S.

Published By: Neuro-Oncology 2010; 12, ii95.

Date: 2010

Title: Targeting MicroRNAs in Glioma Cells with Antineoplastons.

Authors: Patil, S., Burzynski, S.R., Mrowczynski, E., Grela, K.

Published By: Neuro-Oncology 2010; 12, iv10.

Date: 2010

Title: Antineoplastons initiate caspase induced apoptosis by suppressing survivin expression in U87 glioblastoma cells.

Authors: Patil, S., Burzynski, S.R., Mrowczynski, E., Grela, K.

Published By: Neuro-Oncology 2010; 12, ii87.

Date: 2010

Title: Preliminary Results of a Phase II Study of Antineoplastons A10 and AS2-1 (ANP) in Adult Patients with Recurrent Mixed Gliomas.

Authors: Burzynski, S.R, Weaver, R.A., Janicki, T.J., Burzynski, G.S., Szymkowski, B., Acelar, S.S.

Published By: Neuro-Oncology 2010; 12, iv72.

Date: 2009

Title: Phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Protocol BC-BT-11.

Authors: Burzynski, S.R., Janicki, T.J., Weaver, R.A., Szymkowski, B., Burzynski, G.S.

Published By: Neuro-Oncology 2009, 11:951.

Date: 2009

Title: Over a 10-year survival and complete response of a patient with diffuse intrinsic brainstem glioma (DBSG) treated with antineoplastons (ANP).

Authors: Weaver, R.A., Szymkowski, B., Burzynski, S.R.

Published By: Neuro-Oncology 2009; 11:923.

Date: 2009

Title: The Coming Pandemic of Liver Cancer. In Search of Genomic Solutions.

Authors: Burzynski, S.R.

Published By: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics, Volume XI; 2009.

Date: 2009

Title: Practical application of gene silencing theory of aging. Life extension in animal testing and human clinical trials.

Authors: Burzynski, S.R.

Published By: In: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics, Volume XI; 2009. DOI:10.13140/2.1.4353.8888

Date: 2008

Title: Genomic approach to cancer treatment.

Authors: Burzynski, S.R.

Published By: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics, Volume X; 2008; 37-44.

Date: 2008

Title: Phase II study of antineoplastons A10 and AS2-1 (ANP) in patients with newly diagnosed anaplastic astrocytoma: A preliminary report.

Authors: Burzynski, S.R., Weaver, R., Janicki, T., Burzynski, G., Samuel, S., Szymkowski, B.

Published By: Neuro-Oncology 2008; 10:821.

Date: 2008

Title: Phase II study of antineoplastons A10 and AS2-1 infusions (ANP) in patients with recurrent anaplastic astrocytoma.

Authors: Burzynski, S.R., Weaver, R., Janicki, T., Szymkowski, B., Burzynski, G.

Published By: Neuro-Oncology 2008; 10:1067.

Date: 2008

Title: Antineoplaston AS2-1 affects cell cycle checkpoints, leading to apoptosis in human glioblastoma cells.

Authors: Patil, S., Burzynski, S.R., Chittur, S., Mrowczynski, E., Grela, K.

Published By: Neuro-Oncology 2008; 10:786.

Date: 2008

Title: Phase II study of antineoplastons A10 and AS2-1 (ANP) in children with optic pathway glioma: A preliminary report.

Authors: Burzynski, S.R., Weaver, R.A., Janicki, T.J., Walczak, M., Szymkowski, B.G., Samuel, S.

Published By: Neuro-Oncology 2008; 10:450.

Date: 2008

Title: Geny Zycia. (The genes of life)

Authors: Burzynski, S.R.

Published By: Wydawnictwo Farmapress. Czasopismo Aptekarskie. Warszawa 2008.
2007-1997 Science Publications: Date: 2007

Title: Recent clinical trials in diffuse intrinsic brainstem glioma.

Authors: Burzynski, S.R.

Published By: Cancer Therapy 2007; 5, 379-390.

Date: 2007

Title: A case report of a complete response and 20-year survival of a patient with a recurrent diffuse intrinsic brainstem anaplastic astrocytoma.

Authors: Burzynski, S.R., Weaver, R., Szymkowski, B.

Published By: Neuro-Oncology 2007; 9:536.

Date: 2007

Title: Phenylacetylglutamine (PG) and phenylacetate (PN) interact additively to produce detachment-induced apoptosis/anoikis in glioblastoma cells.

Authors: Patil, S., Burzynski, S.R., Mrowczynski, E., Grela, K.

Published By: Neuro-Oncology 2007; 9:482.

Date: 2007

Title: The Genetic Solution for Anti-Aging. Chapter 10.

Authors: Burzynski, S.R.

Published By: In: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics, Volume IX; 2007; 63-70.

Date: 2007

Title: Genetics of Brain Aging (I). Gene Silencing in Neurons. Chapter 11.

Authors: Burzynski, S.R.

Published By: In: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics, Volume IX; 2007; 71-78.

Date: 2007

Title: Phase II studies of Antineoplastons A10 and AS 2-1 (ANP) in children with newly diagnosed diffuse, intrinsic brainstem gliomas.

Authors: Burzynski, S.R., Weaver, R.A., Janicki, T.J., Jurida, G.F., Szymkowski, B.G., Kubove, E.

Published By: Neuro-Oncology 2007; 9:206.

Date: 2007

Title: The breakthrough in therapy and prevention in medicine of 21st century (5). Genes and aging of the neurons. Geny a starzenie neuronow.

Authors: Burzynski, S.R.

Published By: Czasopismo Aptekarskie 2007; Nr 3 (159) 27-38.

Date: 2007

Title: The breakthrough in therapy and prevention in medicine of 21st century (4). Time factor in biology and medicine. Czynnik czasu w biologii i medycynie.

Authors: Burzynski, S.R.

Published By: Czasopismo Aptekarskie 2007; Nr 2 (158) 27-36.

Date: 2007

Title: The breakthrough in therapy and prevention in medicine of 21st century (3). The medicine of aging population. Medycyna starzejacego sie spoleczenstwa.

Authors: Burzynski, S.R.

Published By: Czasopismo Aptekarskie 2007; Nr 1 (157) 39-48.

Date: 2006

Title: The breakthrough in therapy and prevention in medicine of 21st century (2). Epigenome and gene silencing. Epigenom i wyciszanie genow.

Authors: Burzynski, S.R.

Published By: Czasopismo Aptekarskie 2006; Nr 12 (156) 29-36.

Date: 2006

Title: Targeted Therapy for Brain Tumors.

Authors: Burzynski, S.R.

Published By: Editor: Andrew V Yang. Brain Cancer Therapy and Surgical Interventions. New York (NY); Nova Science Publishers, Inc. 2006; 77-111.

Date: 2006

Title: The breakthrough in therapy and prevention in medicine of 21st century (1). The medicine of genome an epigenome. Medycyna genomu i epigenomu.

Authors: Burzynski, S.R.

Published By: Czasopismo Aptekarskie 2006; Nr 11 (155) 45-52.

Date: 2006

Title: Age Management Treatments Which Target Silenced Genes.

Authors: Burzynski, S.R.

Published By: Redberry GW, ed. Gene Silencing: New Research. Nova Science Publishers, Inc. 2006.

Date: 2006

Title: Treatment of multicentric brainstem gliomas with antineoplastons (ANP) A10 and AS2-1.

Authors: Burzynski, S.R., Janicki, T.J., Weaver, R.A., Szymkowski, B.G., Khan, M.I., Dolgopolov, V.

Published By: Neuro-Oncology. 2006; 8:466.

Date: 2006

Title: Complete response of a diffuse intrinsic brainstem tumor and von Hippel Lindau (VHL) disease to antineoplastons A10 and AS2-1 (ANP): a case report.

Authors: Burzynski, S.R., Weaver, R.A., Szymkowski, B., Janicki, T.J., Khan, M.I., Dolgopolov, V.

Published By: Neuro-Oncology. 2006; 8:439.

Date: 2006

Title: Treatments for Astrocytic Tumors in Children: Current and Emerging Strategies.

Authors: Burzynski, S.R.

Published By: Pediatric Drugs 2006; 8: 167-178.

Date: 2006

Title: Targeted therapy with Antineoplastons A10 and AS2-1 of high grade, recurrent, and progressive brainstem glioma.

Authors: Burzynski, S.R., Janicki, T.J., Weaver, R.A., Burzynski, B.

Published By: Integrative Cancer Therapies 2006; 5(1):40-47.

DOI:10.1177/1534735405285380

Date: 2006

Title: Master Clock of Life (II). How to Turn the Clock Back. In: American Academy of Anti-Aging Medicine.

Authors: Burzynski, S.R.

Published By: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics; Volume VIII 2006.

Date: 2006

Title: Phase II studies of antineoplastons A10 and AS2-1 (ANP) in adult patients with diffuse intrinsic brain stem gliomas.

Authors: Burzynski, S.R., Weaver, R.A., Janicki, T.J., Szymkowski, B.G., Jurida, G.F., Burzynski, B.

Published By: Neuro-Oncology. 2006; 8:346.

Date: 2006

Title: Master Clock of Life (I). “Junk DNA.” and Promoters Regions as Major Components of the Clock.

Authors: Burzynski, S.R.

Published By: American Academy of Anti-Aging Medicine (A4M) Anti-Aging Therapeutics; Volume VIII 2006.

Date: 2005

Title: Gene silencing theory of aging: the clinical trial supporting the theory.

Authors: Burzynski, S.R.

Published By: Anti-Aging Therapeutics Vol VII, 2005; 39-46.

Date: 2005

Title: Targeted therapy with ANP in children less than 4 years old with inoperable brain stem gliomas.

Authors: Burzynski, S.R., Weaver, R.A., Janicki, T.J., Burzynski, B., Jurida, G.

Published By: Neuro-Oncology. 2005; 7:300.

Date: 2005

Title: Long-term survival in patients with glioblastoma multiforme treated in phase II studies with ANP.

Authors: Weaver, R.A., Burzynski, S.R., Janicki, T.J., Burzynski, B., Jurida, G., Szymkowski, B.

Published By: Neuro-Oncology. 2005; 7:299.

Date: 2005

Title: Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with Antineoplastons A10 and AS2-1.

Authors: Burzynski, S.R., Weaver, R.A., Janicki, T., Szymkowski, B., Jurida, G., Khan, M., Dolgopolov, V.

Published By: Integrative Cancer Therapies 2005; 4(2): 168-177

Date: 2005

Title: Aging: Gene silencing or gene activation?

Authors: Burzynski, S.R.

Published By: Med Hypoth. 2005; 64, 201-208.

Date: 2004

Title: Mechanizmy i profilaktyka genetycznego starzenia. Mechanisms and prevention of genetic aging.

Authors: Burzynski, S.R.

Published By: Neurologia I Psychiatria 2004; 4:1-8.

Date: 2004

Title: Antineoplastons In Dairy Products.

Authors: Burzynski, S.R., Ilkowska-Musial, E., Klimczak, M.W., Musial, L.

Published By: Journal of Applied Nutrition. 2004; 54; 1-8.

Date: 2004

Title: Phase II studies of antineoplastons A10 and AS2-1 (ANP) in children with atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. A preliminary report.

Authors: Burzynski, S.R., Weaver, R. Bestak, M., Janicki, T., Jurida, G., Szymkowski, B., Khan, M., Dolgopolov, V.

Published By: Neuro-Oncology. 2004; 6: 427.

Date: 2004

Title: Treatment of primitive neuroectodermal tumors (PNET) with antineoplastons A10 and AS2-1 (ANP). Preliminary results of phase II studies.

Authors: Burzynski, S.R., Weaver, R. Bestak, M., Janicki, T., Jurida, G., Szymkowski, B., Khan, M., Dolgopolov, V.

Published By: Neuro-Oncology. 2004; 6: 428.

Date: 2004

Title: Long-term survivals in phase II studies of Antineoplastons A10 and AS2-1 (ANP) in patients with diffuse intrinsic brain stem glioma.

Authors: Burzynski, S.R., Weaver, R. Bestak, M., Lewy, R.I., Janicki, T., Jurida, G., Szymkowski, B., Khan, M., Dolgopolov, V.

Published By: Neuro-Oncology. 2004; 6: 386.

Date: 2004

Title: Phase II study of Antineoplastons A10 and AS2-1 (ANP) in recurrent glioblastoma multiforme.

Authors: Weaver, R.A., Burzynski, S.R., Bestak, M., Lewy, R.I., Janicki, T.J., Szymkowski, B., Jurida, G., Khan, M.I., Dolgopolov, V.

Published By: Neuro-Oncology. 2004; 6: 384.

Date: 2004

Title: Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.

Authors: Burzynski, S.R., Lewy, R.I., Weaver, R., Janicki, T., Jurida, G., Khan, M., Larisma, C.B., Paszkowiak, J., Szymkowski, B.

Published By: Integrative Cancer Therapies. 2004; 3: 257-261.

DOI: 10.1177/1534735404267748

Date: 2004

Title: Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma. A Preliminary Report.

Authors: Burzynski, S.R., Weaver, R., Lewy, R., Janicki, T. Jurida, G., Szymkowski, B., Khan, M., Bestak, M.

Published By: Drugs R&D 2004; 5 (6): 315-326.

Date: 2004

Title: The Present State of Antineoplaston Research.

Authors: Burzynski, S.R.

Published By: Integrative Cancer Therapies 2004; 3: 47-58.

Date: 2003

Title: Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Recurrent Diffuse Intrinsic Brain Stem Glioma.

Authors: Burzynski, S.R., Lewy, R.I., Weaver, R.A., Axler, M.L., Janicki, T.J., Jurida, G.F., Paszkowiak, J.K., Szymkowski, B.G., Khan, M.I., Bestak, M.

Published By: Drugs in R&D 2003; 4: 91-101.

DOI: 10.2165/00126839-200304020-00002

Date: 2003

Title: Phase II study of Antineoplastons A10 and AS2-1 (ANP) in children with recurrent and progressive multicentric glioma. A preliminary report.

Authors: Burzynski, S.R., Weaver, R.A., Bestak, M., Lewy, R.I., Janicki, T.J., Jurida, G.F., Paszkowiak, J.K., Szymkowski, B.G., Khan, M.I.

Published By: Neuro-Oncology. 2003; 5: 358.

Date: 2003

Title: Mechanism of action, uptake, and gene array studies on the antineoplastic agent phenylacetylglutamine (PG) in human glioma cells U-87.

Authors: Waldbillig, R., Burzynski, S.R.

Published By: Neuro-Oncology. 2003; 5: 309.

Date: 2003

Title: Theories of Aging. Old and New Concepts of the Aging Process.

Authors: Giampapa, V.C., Burzynski, S.R., Pero, R.

Published By: The Basic Principles and Practice of Anti-Aging Medicine & Age Management for the Aesthetic Surgeon and Physician. Vincent C. Giampapa (Ed.) 2003; 25-38

Date: 2003

Title: Gene Silencing - A New Theory of Aging.

Authors: Burzynski, S.R.

Published By: Med Hypoth. 2003; 60: 578-583.

Date: 2003

Title: Amino Acid Supplementation in Treatment of Cancer-Related Symptoms.

Authors: Burzynski, S.R., Maxwell L., Lewy, A.R., Janicki, T., Ilkowska-Musial, E., Baranowska, A.

Published By: Journal of Applied Nutrition 2003; 53:52-60.

Date: 2000

Title: Antineoplastons.

Authors: Burzynski, S.R.

Published By: In: Clinician's Complete Reference To Complementary/Alternative Medicine, Novey, D. W. (Ed.). Mosby 2000; 496-507, St.Louis, USA.

Date: 2000

Title: The Best of Alternative Medicine.

Authors: Burzynski, S.R.

Published By: Townsend Letter for Doctors 2000; 200: 32.

Date: 1999

Title: A Retrospective Study of Antineoplastons A10 and AS2-1 in Primary Brain Tumors.

Authors: Burzynski, S.R., Conde, A.B., Peters, A., Saling, B., Ellithorpe, R., Daugherty, J.P., Nacht, C.H.

Published By: Clin. Drug Invest. 1999; 18: 1-10.https://doi.org/10.2165/00044011-199918010-00001

Date: 1999

Title: Efficacy of Antineoplastons A10 and AS2-1.

Authors: Burzynski, S.R.

Published By: Mayo Clin. Proc. 1999; 74: 641-643.

Date: 1998

Title: Antineoplastons in the treatment of malignant brain tumors.

Authors: Burzynski, S.R.

Published By: Anti-Aging Medical Terapeutics, vol. 2. Klatz RM., Goldman R. (Ed), Health Quest Publications 1998; 28-34, Marina del Rey, Ca, USA.

Date: 1997

Title: Antineoplastons, oncogenes and cancer.

Authors: Burzynski, S.R.

Published By: Anti-Aging Medical Therapeutics, vol.1. Klatz RM, Goldman R. (Ed), Health Quest Publication 1997; Marina del Rey, CA, USA.
1996-1986 Science Publications: Date: 1995

Title: Potential of antineoplastons in diseases of old age.

Authors: Burzynski, S.R.

Published By: Drugs & Aging. 1995; 7: 157-167.

Date: 1995

Title: Cellular accumulation of antineoplaston AS2-1 in human hepatoma cells.

Authors: Soltysiak-Pawluczuk, D., Burzynski, S.R., Feldo, M., Majewska, B., Kleinrok, Z.

Published By: Cancer Letters 88 (1995); 88: 107-112.

Date: 1995

Title: The influence of antineoplaston A5 on particular subtypes of central dopaminergic receptors.

Authors: Juszkiewicz, M., Chodkowska, A., Burzynski, S.R., Mlynarczyk, M., Kleinrok, Z.

Published By: Drugs Exptl Clin Res. 1995; 21: 153-156.

Date: 1994

Title: The influence of antineoplaston A5 on the central dopaminergic structures.

Authors: Juszkiewicz, M., Chodkowska, A., Burzynski, S.R., Feldo, M., Majewska, B., Kleinrok, Z.

Published By: Drugs Exptl Clin Res. 1994; 20: 161-167.

Date: 1993

Title: Immunosurveillance versus chemosurveillance.

Authors: Burzynski, S.R.

Published By: Post Nauk Med. 1993; 6: 260-262.

Date: 1993

Title: Antineoplastons. An Investigational Cancer Therapy.

Authors: Burzynski, S.R.

Published By: Townsend Letter for Doctors 1993; 3, 150-153

Date: 1992

Title: Novel differentiation inducers.

Authors: Burzynski, S.R.

Published By: Recent Advances in Chemotherapy. Adam D. (Ed), Futuramed Publishers. 1992; Munich, Germany.

Date: 1992

Title: Potentiation of induced terminal differentiation by phenylacetic acid and related chemicals.

Authors: Liau, M.C., Liau, C.P., Burzynski, S.R.

Published By: Internat J Exptl Clin Chemother. 1992; 5: 9-17.

Date: 1992

Title: Prevention of drug induced DNA hypermethylation by antineoplaston components.

Authors: Liau, M.C., Luong, Y., Liau, C.P., Burzynski, S.R.

Published By: Internat J Exptl Clin Chemother. 1992; 5: 19-27.

Date: 1992

Title: Synergistic Effect of Antineoplaston A5 and Retinoic Acid on the Induction of Human Promyelocytic Leukemia line HL-60.

Authors: Lee, S.S., Burzynski, S.R.

Published By: Recent Advances in Chemotherapy. Adam D. (Ed), Futuramed Publishers. 1992: Munich, Germany.

Date: 1992

Title: Prevention of drug-induced DNA hypermethylation by antineoplastons.

Authors: Liau, M.C., Luong, Y., Liau, C.P., Burzynski, S.R.

Published By: Recent Advances in Chemotherapy. Adam D. (Ed), Futuramed Publishers. 1992; Munich, Germany.

Date: 1992

Title: Phase II clinical trials of antineoplastons A10 and AS2-1 infusions in astrocytoma.

Authors: Burzynski, S.R, Kubove, E., Burzynski, B.

Published By: Recent Advances in Chemotherapy. Adam Dieter. (Ed), Futuramed Publishers. 1992; Munich, Germany.

Date: 1991

Title: Antineoplaston A5: A growth inhibitor for cancerous cells and growth stimulator for normal cells.

Authors: Lee, S.S., Burzynski, S.R.

Published By: Internat J Exptl Clin Chemother. 1991; 4: 63-65.

Date: 1990

Title: Protective effect of antineoplaston A10 in hepatocarcinogenesis induced by aflatoxin B1.

Authors: Kampalath, B.N., Liau, M.C., Burzynski, B., Burzynski, S.R.

Published By: Internat J Tissue Reactions. 1990; 12 (suppl): 43-50.

Date: 1990

Title: Modulation of cancer methylation complex isoenzymes as a decisive factor in the induction of terminal differentiation mediated by antineoplaston A5.

Authors: Liau, M.C., Lee, S.S., Burzynski, S.R.

Published By: Internat J Tissue Reactions. 1990; 12 (suppl): 27-36.

Date: 1990

Title: Inducibility of HL-60 leukemic cells to undergo terminal differentiation after repeated treatment with antineoplaston A5.

Authors: Lee, S.S., Burzynski, S.R.

Published By: Internat J Exptl Clin Chemother. 1990; 3: 125-128.

Date: 1990

Title: Induction of differentiation of HL-60 human promyelocytic leukemic cell by antineoplaston A5.

Authors: Lee, S.S., Burzynski, S.R.

Published By: Internat J Tissue Reactions. 1990; 12 (suppl): 37-42.

Date: 1990

Title: Riboflavin as a minor active anticancer component of antineoplaston A2 and A5.

Authors: Liau, M.C., Ashraf, A.Q., Lee, S.S., Hendry, L.B., Burzynski, S.R.

Published By: Internat J Tissue Reactions. 1990; 12: 19-26.

Date: 1990

Title: Separation of active anticancer components of antineoplaston A2, A3, and A5.

Authors: Liau, M.C., Lee, S.S., Burzynski, S.R.

Published By: Internat J Tissue Reactions. 1990; 12 (suppl): 1-17.

Date: 1990

Title: Treatment of hormonally refractory cancer of the prostate with antineoplaston AS2-1.

Authors: Burzynski, S.R., Kubove, E., Burzynski, B.

Published By: Drugs Exptl Clin Res. 1990; 16: 361-369.

Date: 1989

Title: Isolation, purification and synthesis of antineoplastons.

Authors: Burzynski, S.R.

Published By: Internat J Exptl Clin Chemother. 1989; 2: 63-69.

Date: 1989

Title: Hypomethylation of nucleic acids: A key to the induction of terminal differentiation.

Authors: Liau, M.C., Lee, S.S., Burzynski, S.R.

Published By: Internat J Exptl Clin Chemother. 1989; 2: 187-199.

Date: 1988

Title: Modeling studies suggest the modified dipeptide analog phenylacetylamino-2, 6-piperidinedione may interact with DNA.

Authors: Hendry, L.B., Muldoon, T.G., Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 2: 11-13.

Date: 1988

Title: Antineoplastons: Basic research and clinical applications.

Authors: Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 2: 1-9.

Date: 1988

Title: Isolation, purification and synthesis of antineoplastons.

Authors: Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 6: 1-7.

Date: 1988

Title: Differentiation inducing components of antineoplaston A5.

Authors: Liau, M.C., Lee, S.S, Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 6: 9-25.

Date: 1988

Title: Terminal differentiation of HL-60 human promyelocytic leukemia cells induced by antineoplaston A2.

Authors: Lee, S.S., Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 6: 27-31.

Date: 1988

Title: Treatment of bladder cancer with antineoplaston formulations.

Authors: Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988. 2: 37-46.

Date: 1988

Title: Phase I clinical studies of oral formulation of antineoplaston AS2-1.

Authors: Burzynski, S.R., Kubove, E., Burzynski, B.

Published By: Adv Exptl Clin Chemother. 1988; 2: 29-36.

Date: 1988

Title: Treatment of malignant brain tumors with antineoplastons.

Authors: Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 6: 45-56.

Date: 1988

Title: Pharmacokinetic analysis of antineoplaston A10 injections following intravenous administration in rats.

Authors: Ashraf, A.Q., Kampalath, B.N., Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 6: 33-39.

Date: 1988

Title: Comparative study of antineoplaston A10 levels in plasma of healthy people and cancer patients.

Authors: Ashraf, A.Q., Burzynski, S.R.

Published By: Adv Exptl Clin Chemother. 1988; 2: 19-28.

Date: 1987

Title: Tissue culture and animal toxicity studies of antineoplaston A5.

Authors: Lee, S.S., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 31-35.

Date: 1987

Title: Chemoprevention by antineoplaston A10 of benzo (a) pyrene-induced pulmonary neoplasia.

Authors: Kampalath, B.N., Liau, M.C., Burzynski, B., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 51-55.

Date: 1987

Title: Chemosurveillance: A novel concept of the natural defense mechanism against cancer.

Authors: Liau, M.C., Szopa, M., Burzynski, B., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 71-76.

Date: 1987

Title: In vitro cancer growth inhibition and animal toxicity studies of antineoplaston A3.

Authors: Lee, S.S., Mohabbat, M.O., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 13-16.

Date: 1987

Title: N,N'-disubstituted L-isoglutamines as novel cancer chemotherapeutic agents.

Authors: Khalid, M., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 57-60.

Date: 1987

Title: Stereochemical modeling studies of the interaction of antineoplaston A10 with DNA.

Authors: Hendry, L.B., Muldoon, T.G., Burzynski, S.R., Copland, J.A., Lehner, A.F.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 77-81.

Date: 1987

Title: Initial clinical study with antineoplaston A2 injections in cancer patients with five years' follow-up.

Authors: Burzynski, S.R., Kubove, E.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 1-12.

Date: 1987

Title: Phase I clinical studies of antineoplaston A3 injections.

Authors: Burzynski, S.R., Kubove, E.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 17-29.

Date: 1987

Title: Phase I clinical studies of antineoplaston A5 injections.

Authors: Burzynski, S.R., Kubove, E., Burzynski, B.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 37-43.

Date: 1987

Title: Quantitative assay of plasma and urinary peptides as an aid for the evaluation of cancer patients undergoing antineoplaston therapy.

Authors: Liau, M.C., Szopa, M., Burzynski, B., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 61-70.

Date: 1987

Title: Pharmacokinetic study of radioactive antineoplaston A10 following oral administration in rats.

Authors: Ashraf, A.Q., Liau, M.C., Kampalath, B.N., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1987; 13 (suppl 1): 45-50.

Date: 1986

Title: Chronic animal toxicity studies of antineoplaston A2.

Authors: Burzynski, S.R., Mohabbat, M.O.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 73-75.

Date: 1986

Title: Preclinical studies on antineoplaston A10 injections.

Authors: Ashraf, A.Q., Liau, M.C., Mohabbat, M.O., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 37-45.

Date: 1986

Title: Preclinical studies on antineoplaston AS2-1 and antineoplaston AS2-5.

Authors: Burzynski, S.R., Mohabbat, M.O., Lee, S.S.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 11-16.

Date: 1986

Title: Antineoplaston A3.

Authors: Burzynski, S.R.

Published By: Drugs of the Future 1986; 11: 551-552.

Date: 1986

Title: Antineoplastons: History of the research (I)

Authors: Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 1-9.

Date: 1986

Title: Antineoplaston AS2-5.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1986; 8: 319.

Date: 1986

Title: Antineoplaston AS2-1.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1986; 8: 320.

Date: 1986

Title: Antineoplaston AS2-5.

Authors: Burzynski, S.R., Khalid, M.

Published By: Drugs of the Future 1986; 11: 364-365.

Date: 1986

Title: Antineoplaston A10 injections.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1986; 8: 597.

Date: 1986

Title: Antineoplaston A3.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1986; 8: 412.

Date: 1986

Title: Antineoplaston A2.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1986; 8: 504.

Date: 1986

Title: Antineoplaston AS2-1.

Authors: Burzynski, S.R., Khalid, M.

Published By: Drugs of the Future 1986; 11: 361-363.

Date: 1986

Title: Antineoplaston A2.

Authors: Burzynski, S.R.

Published By: Drugs of the Future 1986; 11: 549-550.

Date: 1986

Title: Antineoplaston A5.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1986; 8: 869.

Date: 1986

Title: Antineoplaston A5.

Authors: Burzynski, S.R.

Published By: Drugs of the Future 1986; 11: 824-825.

Date: 1986

Title: Synthetic antineoplastons and analogs.

Authors: Burzynski, S.R.

Published By: Drugs of the Future 1986; 11: 679-688.

Date: 1986

Title: Altered methylation complex isoenzymes as selective targets for cancer chemotherapy.

Authors: Liau, M.C., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 77-86.

Date: 1986

Title: 3-phenylacetylamino-2,6-piperidinedione, a naturally occurring peptide analogue with apparent antineoplastic activity, may bind to DNA.

Authors: Lehner, A.F., Burzynski, S.R., Hendry, L.B.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 57-72.

Date: 1986

Title: Toxicology studies on antineoplaston A10 injections in cancer patients.

Authors: Burzynski, S.R., Kubove, E.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 47-55.

Date: 1986

Title: Toxicology studies of antineoplaston AS2-5 injections in cancer patients.

Authors: Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 17-24.

Date: 1986

Title: Toxicology studies on antineoplaston AS2-1 injections in cancer patients.

Authors: Burzynski, S.R., Burzynski, B., Mohabbat, M.O.

Published By: Drugs Exptl Clin Res. 1986; 12 (suppl 1): 25-35.
1985-1975 Science Publications: Date: 1985

Title: Tissue culture and acute animal toxicity studies of antineoplaston A2.

Authors: Lee, S.S., Mohabbat, M.O., Burzynski, S.R.

Published By: Future Trends in Chemotherapy 1985; 6: 481-484.

Date: 1985

Title: Antineoplaston A10.

Authors: Burzynski, S.R., Hai, TT.

Published By: Drugs of the Future 1985; 10: 103-105.

Date: 1985

Title: Phase I clinical studies of antineoplaston AS2-5 injections.

Authors: Burzynski, S.R.

Published By: Recent Advances in Chemotherapy. Ishigami J. (Ed), University of Tokyo Press. Proceeding of the 14th International Congress of Chemotherapy, Kyoto, 1985, 586-7.

Date: 1985

Title: Toxicology studies on oral formulation of antineoplaston A10 in cancer patients.

Authors: Burzynski, S.R., Mohabbat, M.O., Burzynski, B.

Published By: Future Trends in Chemotherapy 1985; 6: 485-493.

Date: 1984

Title: Animal toxicology studies on oral formulation of antineoplaston A10.

Authors: Burzynski, S.R., Mohabbat, M.O., Burzynski, B.

Published By: Drugs Exptl Clin Res. 1984; 10: 113-118.

Date: 1984

Title: Tissue culture and animal toxicity studies of antineoplaston A2.

Authors: Lee, S.S., Mohabbat, M.O., Burzynski, S.R.

Published By: Drugs Exptl Clin Res. 1984; 10: 607-610.

Date: 1984

Title: Antineoplaston A10.

Authors: Burzynski, S.R.

Published By: Annual Drug Data Report. 1984; 6: 124.

Date: 1984

Title: Human toxicology studies on oral formulation of antineoplaston A10.

Authors: Burzynski, S.R., Mohabbat, M.O., Burzynski, B.

Published By: Drugs Exptl Clin Res. 1984; 10: 891-909.

Date: 1984

Title: Toxicology studies on oral formulation of antineoplaston A10 in cancer patients.

Authors: Burzynski, S.R., Mohabbat, M.O., Burzynski, B.

Published By: Drugs Exptl Clin Res. 1984; 10: 611-619.

Date: 1979

Title: Polypeptides that inhibit human breast cancer cell division.

Authors: Beall, P., Szopa, B., Burzynski, S.R., Hazlewood, C.F.

Published By: Cancer Biochem Biophys. 1979; 3: 93-96.

Date: 1978

Title: Antyneoplastony.

Authors: Burzynski, S.R.

Published By: Przeglad Lekarski. 1978; 6: 583-586.

Date: 1977

Title: Urinary peptides inhibit DNA synthesis in vitro in certain cultured neoplastic cells.

Authors: Gross, S., Galicka, N., Grabarczyk, M., Giannini, M., Burzynski, S.R., Stolzmann, Z.

Published By: Clin Chem. 1977; 23: 148-149.

Date: 1977

Title: Antineoplaston A in cancer therapy (I).

Authors: Burzynski, S.R., Stolzmann, Z., Szopa, B., Stolzmann, E., Kaltenberg, O.P.

Published By: Physiol Chem Phys. 1977; 9: 485-500.

Date: 1976

Title: Antineoplastons: Biochemical defense against cancer.

Authors: Burzynski, S.R.

Published By: Physiol Chem Phys. 1976; 8: 275-279.

Date: 1976

Title: Urinary peptides in muscular dystrophy.

Authors: Gross, S., Galicka, N., Burzynski, S.R., Stolzmann, A.

Published By: Physiol Chem Phys. 1976; 8: 161-166.

Date: 1976

Title: Sequential analysis in subnanomolar amounts of peptides; Determination of the structure of a habituation-induced brain peptide (ameletin).

Authors: Burzynski, S.R.

Published By: Anal Biochem. 1976; 70: 359-365.

Date: 1976

Title: Biologically active peptides in human urine: III. Inhibitors of the growth of leukemia, osteosarcoma and HeLa cells.

Authors: Burzynski, S.R., Loo, T.L., Ho, D.H., Rao, P.N., Georgiades, J., Kratzenstein, H.

Published By: Physiol Chem Phys. 1976; 8: 13-22.

Date: 1976

Title: Inhibition of the Growth of HeLa Cells by the Peptide Isolated from Normal Human Urine.

Authors: Burzynski, S.R., Rao, P.N., Gross, S., Stolzman, Z.

Published By: Fed Proc. 1976; 35: 623.

Date: 1975

Title: Quantitative analysis of amino acids and peptides in the femtomolar range.

Authors: Burzynski, S.R.

Published By: Anal Biochem. 1975; 65: 93-99.

Date: 1975

Title: Brain Peptides Associated with Habituation to a Sound Stimulus.

Authors: Burzynski, S.R., Ungar, G.

Published By: Neuroscience Abstracts. 1975; 1: 329.

Date: 1975

Title: Learning-induced Brain Peptides.

Authors: Ungar, G., Burzynski, S.R., Tate, D.L.

Published By: Peptides: Chemistry, structure and biology. Walter, R., Meienhofer, J. (Ed), Ann Arbor Science; 1975; Ann Arbor, Michigan, USA.
1974-1964 Science Publications: Date: 1974

Title: Biologically active peptides in human urine: II. Effect on intestinal smooth muscle and heart.

Authors: Burzynski, S.R., Ungar, A.L., Lubanski, E.

Published By: Physiol Chem Phys. 1974; 6: 457-468.

Date: 1974

Title: Effect of Urinary Peptides on Smooth Muscle and Heart.

Authors: Burzynski, S.R., Ungar, A.L., Lubanski, E.

Published By: Fed Proc. 1974; 33: 547.

Date: 1973

Title: Biologically active peptides in human urine: I. Isolation of a group of medium-sized peptides.

Authors: Burzynski, S.R.

Published By: Physiol Chem Phys. 1973; 5: 437-447.

Date: 1973

Title: Effect of Urinary Peptides on DNA, RNA and Protein Synthesis in Normal and Neoplastic Cells.

Authors: Burzynski, S.R., Georgiades, J.

Published By: Fed Proc. 1973; 32: 766.

Date: 1973

Title: Isolation and Purification of a Habituation-inducing Peptide from Trained Rat Brain.

Authors: Ungar, G., Burzynski, S.R.

Published By: Fed Proc. 1973; 32: 367.

Date: 1970

Title: A simple method for the separation of free and bound amino acids and its application to the identification of bound amino acids in human blood serum.

Authors: Burzynski, S.R., Czerniak, Z.

Published By: Chem Anal. 1970; 15: 223-225.

Date: 1970

Title: Free amino acids in serum of obese children.

Authors: Szajner-Milart, J., Burzynski, S.R., Paczos-Chadyma, E., Czerniak, Z.

Published By: Endokr Pol. 1970; 21: 611-617.

Date: 1969

Title: Quantitative determinations of carbohydrates and their statistical analysis, I. Results obtained in various conditions using paper and thin-layer chromatography.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Chem Anal. 1969; 13: 1221-1228.

Date: 1969

Title: Investigations on unknown ninhydrin-reacting substances in human blood serum I. Attempts at identification of three such substances.

Authors: Burzynski, S.R.

Published By: Experientia. 1969; 25: 490-491.

Date: 1969

Title: Bound amino acids in serum of patients with chronic renal insufficiency.

Authors: Burzynski, S.R.

Published By: Clin Chim Acta. 1969; 25: 231-237.

Date: 1969

Title: Free amino acids in serum of patients with chronic renal insufficiency.

Authors: Czerniak, Z., Burzynski, S.

Published By: Clin Chim Acta. 1969; 24: 367-372.

Date: 1969

Title: A simple method for free and bound amino acid separation.

Authors: Burzynski, S.R., Czerniak, Z.

Published By: Folia Soc Sci Lub. 1969/70; Sec. A-D 9/10 (suppl): 143-144.

Date: 1969

Title: Quantitative determination of amino acids using photometry of negative printed chromatograms. Modification of the method and its application for amino acid analysis in blood serum.

Authors: Burzynski, S.R., Czerniak, Z.

Published By: Chem Anal. 1969; 14: 667-671.

Date: 1969

Title: Qualitative analysis of amino acids using the multiple development of chromatograms in different eluents.

Authors: Czerniak, Z., Burzynski, S.

Published By: Chem Anal. 1969; 14: 673-676.

Date: 1968

Title: Quantitative determinations of free amino acids in human blood with the use of our own method and Beckman amino acid analyzer.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Pol Arch Med Wewn. 1968; 40: 223-228.

Date: 1968

Title: Quantitative determinations of free amino acids in the blood of patients with myocardial infarction using a new method of photometry of the negative printed chromatograms.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Pol Arch Med Wewn. 1968; 41: 361-368.

Date: 1968

Title: Quantitative determinations of carbohydrates and their statistical analysis, II. Analysis of variance for four-crossed classification and Tukey confidence intervals.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Chem Anal. 1968; 13: 1229-1238.

Date: 1968

Title: Investigations on amino acids and peptides in blood serum of healthy people and patients with chronic renal insufficiency.

Authors: Burzynski, S.R.

Published By: Doctoral dissertation. Lublin, Poland, 1968.

Date: 1966

Title: Quantitative determination of amino acids using photometry of negative printed chromatograms.

Authors: Krzeczkowska, I., Burzynski, S., Czerniak, Z.

Published By: Ann Univ MC Sklodowska 1966; 21: 125-134.

Date: 1966

Title: The application of the negative printed chromatograms for quantitative determination of free amino acids in the blood of healthy people.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Ann Univ MC Sklodowska 1966; 21: 313-322.

Date: 1965

Title: Investigations on the possibility of the determination of mushroom species on the basis of the composition of their amino acids.

Authors: Krzeczkowska, I., Burzynski, S., Czerniak, Z.

Published By: Ann Univ MC Sklodowska 1965; 20: 221-229.

Date: 1965

Title: Free and bound amino acids of some edible mushrooms.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Ann Univ MC Sklodowska 1965; 20: 303-312.

Date: 1964

Title: Free amino acids of some edible mushrooms.

Authors: Krzeczkowska, I., Burzynski, S., Czerniak, Z.

Published By: Ann Univ MC Sklodowska 1964; 19: 321-328.

Date: 1964

Title: Bound amino acids of some edible mushrooms.

Authors: Krzeczkowska, I., Czerniak, Z., Burzynski, S.

Published By: Ann Univ MC Sklodowska 1964; 19: 329-336.

Scientific Publications

Pioneering Cancer Research

Publication Highlights

Newly Diagnosed Anaplastic Astrocytoma: > 23 Year Survival in a 31-Year and 11-Month-Old Female Treated with Antineoplastons

Recurrent/Persistent Glioblastoma: Complete Response and 24 Years Disease-free Survival in a 45-Year-Old Female Treated with Antineoplastons (Successful Treatment of Glioblastoma with Antineoplastons).

Newly Diagnosed Glioblastoma: Partial Response and > 27 Years Overall Survival in 37-Year-Old Male Treated with Antineoplastons (Treatment of Glioblastoma with Antineoplastons).

Resolution of clinical signs, a complete response, and long-term survival (> 23 Years) in a 3 and ½ month female with a newly diagnosed diffuse intrinsic pontine glioma treated with antineoplastons.

Long-term Survival (27.7 Years) Following IV Antineoplaston Therapy (ANP) in a 36-Year-Old Female with a Progressive Diffuse Intrinsic Pontine Glioma (DIPG)

Progressive, Multicentric, Midline, Low-grade Glioma: Survival Greater Than 24.8 Years in Three Patients Treated with Antineoplastons A10 and AS2-1 in Phase II Studies

Recurrent/Disseminated Choroid Plexus Carcinoma: Overall Survival of > 23.6 Years in a One-Year and Nine-Month-Old Female Treated with Antineoplastons.

Recurrent Desmoplastic Infantile Ganglioglioma Treated with Antineoplastons: Partial Response and Overall Survival of > 11.8 Years in a Ten-Month-Old Female

Recurrent Pilocytic Astrocytoma: Treatment with Antineoplastons, Complete Response, and > 27 Years Overall Survival

Recurrent Medulloblastoma: Complete Response and > than 21 Years and Five Months Overall Survival in a One-Year and Seven Month-Old Male Treated with Antineoplastons

Inoperable Optic Pathway Glioma: A Seven-Year-Old Male with >35 Years Overall Survival Following Treatment with Antineoplastons

Persistent pineoblastoma: Complete response and >26 years overall survival in a ten-month-old female treated with antineoplastons

BURZYNSKI CLINIC

PATIENT RESOURCES

LEARN MORE

INFO